Nanogel-drug conjugates: A step towards increasing the chemotherapeutic efficacy

Nanomedicine

Volumn 8, Issue 8, 2013, Pages 1229-1232

  Vinogradov, Serguei V ^a   Senanayake, Thulani ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

cell penetration; drug delivery; tumor growth inhibition

Indexed keywords

FLOXURIDINE; GEMCITABINE; NANOCARRIER; NANOCONJUGATE; NANOGEL DRUG CONJUGATE; PEGINTERFERON ALPHA2A; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG METABOLISM; DRUG PENETRATION; DRUG RELEASE; DRUG TRANSPORT; ENCAPSULATION; IONIC STRENGTH; MOLECULAR WEIGHT; PH; PRIORITY JOURNAL; REVIEW; TEMPERATURE;

DRUG DELIVERY SYSTEMS; HUMANS; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; VISCOSITY;

EID: 84893193940     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.13.107     Document Type: Review

References (15)

1. Kabanov AV, Vinogradov SV. Nanogels as pharmaceutical carriers: Finite networks of infinite capabilities. Angew. Chem. Int. Ed. Engl. 48(30), 5418-5429 (2009
2. Vinogradov SV, Batrakova EV, Kabanov AV. Nanogels for oligonucleotide delivery to the brain. Bioconjug. Chem. 15(1), 50-60 (2004
3. Vinogradov SV, Zeman AD, Batrakova EV, Kabanov AV. Polyplex nanogel formulations for drug delivery of cytotoxic nucleoside analogs. J. Control. Release 107(1), 143-157 (2005
4. Nukolova NV, Oberoi HS, Cohen SM, Kabanov AV, Bronich TK. Folate-decorated nanogels for targeted therapy of ovarian cancer. Biomaterials 32(23), 5417-5426 (2011
5. Fang J, Nakamura H, Maeda H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliv. Rev. 63(3), 136-151 (2011
6. Shimoda A, Sawada S, Akiyoshi K. Cell specific peptide-conjugated polysaccharide nanogels for protein delivery. Macromol. Biosci. 11(7), 882-888 (2011
7. Nishiyama N, Okazaki S, Cabral H et al. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res. 63, 8977-8983 (2003
8. Ulbrich K, Etrych T, Chytil P, Pechar M, Jelinkova M, Rihova B. Polymeric anticancer drugs with pH-controlled activation. Int. J. Pharm. 277(1-2), 63-72 (2004
9. Satchi-Fainaro R, Puder M, Davies JW et al. Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nat. Med. 10(3), 255-261 (2005
10. Senanayake TH, Warren G, Vinogradov SV. Novel anticancer polymeric conjugates of activated nucleoside analogues. Bioconjug. Chem. 22 (10), 1983-1993 (2011
11. Senanayake TH, Warren G, Wei X, Vinogradov SV. Application of activated nucleoside analogs for the treatment of drug resistant tumors by oral delivery of nanogel-drug conjugates. J. Control. Release 167(2), 200-209 (2013
12. Wei X, Senanayake TH, Warren G, Vinogradov SV. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug resistant tumors. Bioconjug. Chem. 24(4), 658-668 (2013
13. Vinogradov SV, Kohli E, Zeman AD. Cross linked polymeric nanogel formulations of 5́-Triphosphates of nucleoside analogues: Role of the cellular membrane in drug release. Mol. Pharm. 2(6), 449-461 (2005
14. Vinogradov S, Wei X. Cancer stem cells and drug resistance: The potential of nanomedicine. Nanomedicine (Lond.) 7(4), 597-615 (2012
15. Vinogradov S, Poluektova LY, Makarov E, Gerson T, Senanayake TM. Nano-NRTIs: Efficient inhibitors of HIV type-1 in macrophages with a reduced mitochondrial toxicity. Antiviral Chem. Chemother. 21, 1-14 (2010